| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Laura D Attardi | |
| Stephano S Mello | |||
| P2860 | cites work | Suppression of tumorigenesis by the p53 target PUMA | Q24563144 |
| p53 represses c-Myc through induction of the tumor suppressor miR-145 | Q24644779 | ||
| An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model | Q27853369 | ||
| Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness | Q28077156 | ||
| Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas | Q29616243 | ||
| Metabolic reprogramming: a cancer hallmark even warburg did not anticipate | Q29617612 | ||
| Suppression of induced pluripotent stem cell generation by the p53-p21 pathway | Q29619160 | ||
| Tumorigenesis and the angiogenic switch | Q29619849 | ||
| Non-cell-autonomous tumor suppression by p53. | Q30541182 | ||
| Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression | Q33493417 | ||
| Obligate progression precedes lung adenocarcinoma dissemination | Q33875584 | ||
| Ferroptosis as a p53-mediated activity during tumour suppression | Q34043533 | ||
| p53 Research: the past thirty years and the next thirty years. | Q34313764 | ||
| Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. | Q34449969 | ||
| The pathological response to DNA damage does not contribute to p53-mediated tumour suppression | Q34564198 | ||
| The evolution of thymic lymphomas in p53 knockout mice | Q34590256 | ||
| An oncogene-induced DNA damage model for cancer development | Q34759268 | ||
| p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. | Q34787898 | ||
| A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. | Q35503722 | ||
| Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression | Q35676910 | ||
| p53: traffic cop at the crossroads of DNA repair and recombination | Q36028209 | ||
| The role of p53 in hypoxia-induced apoptosis | Q36113108 | ||
| Paraspeckle nuclear bodies--useful uselessness? | Q36192065 | ||
| p53 genes function to restrain mobile elements | Q36432047 | ||
| miR-34 miRNAs provide a barrier for somatic cell reprogramming | Q36522839 | ||
| Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses | Q36850426 | ||
| p19(Arf) is required for the cellular response to chronic DNA damage | Q37062834 | ||
| P53 and the defenses against genome instability caused by transposons and repetitive elements | Q37272469 | ||
| Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression | Q37581391 | ||
| p53 and its mutants in tumor cell migration and invasion | Q37832072 | ||
| Illuminating p53 function in cancer with genetically engineered mouse models | Q38176221 | ||
| Unravelling mechanisms of p53-mediated tumour suppression | Q38205099 | ||
| Deregulation of DNA methyltransferases and loss of parental methylation at the insulin-like growth factor II (Igf2)/H19 loci in p53 knockout mice prior to tumor development | Q38334289 | ||
| p53 in survival, death and metabolic health: a lifeguard with a licence to kill | Q38540071 | ||
| Neat1 is a p53-inducible lincRNA essential for transformation suppression | Q38683437 | ||
| Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations | Q38705984 | ||
| Cytokinesis failure triggers hippo tumor suppressor pathway activation. | Q38965753 | ||
| Stem cells: The promises and perils of p53. | Q42380567 | ||
| p53 Regulates Progenitor Cell Quiescence and Differentiation in the Airway | Q42502153 | ||
| Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence | Q43120565 | ||
| p53 is essential for DNA methylation homeostasis in naïve embryonic stem cells, and its loss promotes clonal heterogeneity | Q43293646 | ||
| p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. | Q46022806 | ||
| A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer | Q47670514 | ||
| The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity | Q47945423 | ||
| Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53. | Q48093547 | ||
| p53 Activity Results in DNA Replication Fork Processivity. | Q51336015 | ||
| p53 Maintains Genomic Stability by Preventing Interference between Transcription and Replication. | Q51388402 | ||
| Tumour biology: Policing of oncogene activity by p53 | Q57562778 | ||
| P304 | page(s) | 65-72 | |
| P577 | publication date | 2017-11-28 | |
| P1433 | published in | Current Opinion in Cell Biology | Q13505682 |
| P1476 | title | Deciphering p53 signaling in tumor suppression. | |
| P478 | volume | 51 |
| Q90581415 | 5-aminolaevulinic acid-based photodynamic therapy inhibits ultraviolet B-induced skin photodamage |
| Q91964721 | A p53/TIAF1/WWOX triad exerts cancer suppression but may cause brain protein aggregation due to p53/WWOX functional antagonism |
| Q93038215 | A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma |
| Q90482750 | Advances in targeted therapy for malignant lymphoma |
| Q92633778 | Chronic and Acute Toxicities of Aflatoxins: Mechanisms of Action |
| Q57137831 | Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor |
| Q100750134 | Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis |
| Q90699144 | Context is everything: extrinsic signalling and gain-of-function p53 mutants |
| Q58805589 | Control of metabolism by p53 - Cancer and beyond |
| Q92460452 | Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma |
| Q91964954 | Do Mutations Turn p53 into an Oncogene? |
| Q102388925 | Genomic retargeting of p53 and CTCF is associated with transcriptional changes during oncogenic HRas-induced transformation |
| Q91756533 | Identification of microRNA-92a and the related combination biomarkers as promising substrates in predicting risk, recurrence and poor survival of colorectal cancer |
| Q54110522 | Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer. |
| Q92133913 | Integrated analysis of transcriptomic and metabolomic profiling reveal the p53 associated pathways underlying the response to ionizing radiation in HBE cells |
| Q96304262 | Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells |
| Q57020701 | Knockdown of Ubiquitin Associated Protein 2-Like (UBAP2L) Inhibits Growth and Metastasis of Hepatocellular Carcinoma |
| Q98289749 | MAGEA3 promotes proliferation and suppresses apoptosis in cervical cancer cells by inhibiting the KAP1/p53 signaling pathway |
| Q58586893 | Network Pharmacology-Based Validation of Caveolin-1 as a Key Mediator of Ai Du Qing Inhibition of Drug Resistance in Breast Cancer |
| Q60935673 | Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype |
| Q101226655 | P53 clears aneuploid cells by entosis |
| Q90322572 | Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells |
| Q94554680 | Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21 |
| Q93016086 | Regulation of expression of drug-metabolizing enzymes by oncogenic signaling pathways in liver tumors: a review |
| Q90149418 | Replication stress induces mitotic death through parallel pathways regulated by WAPL and telomere deprotection |
| Q93095094 | Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses |
| Q92525864 | Siva plays a critical role in mouse embryonic development |
| Q64117460 | Specific allelic variants of SNPs in the and genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients |
| Q90583577 | Synergetic Impact of Combined 5-Fluorouracil and Rutin on Apoptosis in PC3 Cancer Cells through the Modulation of P53 Gene Expression |
| Q91239428 | TRMP, a p53-inducible long noncoding RNA, regulates G1/S cell cycle progression by modulating IRES-dependent p27 translation |
| Q55180659 | The Guardian of the Genome Revisited: p53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere Structure. |
| Q90320875 | The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number |
| Q90640357 | The Tip of an Iceberg: Replication-Associated Functions of the Tumor Suppressor p53 |
| Q52309402 | The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis. |
| Q92646659 | The reactivation of P53 by saRNA affects the biological behavior in vitro in gastric cancer cells |
| Q92427915 | Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis |
| Q90022420 | WDR63 inhibits Arp2/3-dependent actin polymerization and mediates the function of p53 in suppressing metastasis |
| Q64290120 | ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation |
| Q90108778 | Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination |
| Q91962958 | p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative Mechanisms |
| Q92493122 | p63 at the Crossroads between Stemness and Metastasis in Breast Cancer |
| Q64062966 | ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment |
Search more.